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Introduction: Dystonia-deafness syndrome is a distinct clinical presentation within the 
dystonia spectrum. Although several genetic and acquired causes have been reported, 
etiology remains unknown in the majority of patients.
Objectives: To describe two patients with dystonia-deafness syndrome due to a beta-actin 
gene mutation.
Methods: We report on disease course, genetic testing, and management of two patients, 
mother and daughter, presenting with dystonia-deafness syndrome.
Results: After exclusion of known dystonia-deafness syndrome causes, whole-exome 
sequencing revealed a beta-actin gene mutation (p.Arg183Trp) in both patients. Although 
beta-actin gene mutations are generally associated with developmental Baraitser-Winter 
syndrome, dystonia-deafness syndrome has been reported once in identical twin brothers. 
Bilateral GPi-DBS led to a significant decrease of dystonia and regain of independency in 
our patients.
Conclusion: The p.Arg183Trp mutation in the beta-actin gene is associated with the clinical 
presentation of dystonia-deafness syndrome, even with only minimal or no developmental 
abnormalities of Baraitser-Winter syndrome. GPi-DBS should be considered to ameliorate 
the invalidating dystonia in these patients.
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INTRODUCTION
Dystonia is a movement disorder characterized by sustained or intermittent muscle con-
tractions causing abnormal, often patterned, movements and/or postures. A combination 
of dystonia and sensory-neural deafness, referred to as dystonia-deafness syndrome 
(DDS), is a distinct clinical presentation within the dystonia spectrum. Several genetic 
and acquired causes are associated with DDS, but the etiology remains undetermined in 
most patients.[1]
PATIENTS AND METHODS
We describe two patients, mother and daughter, presenting with DDS. The index patient was 
a 22-year-old woman with congenital sensory-neural deafness, generalized dystonia, and 
remarkably high-arched eyebrows (Fig. 1A). At the age of 19, dystonic symptoms started 
with writer’s cramp and progressed to severe generalized dystonia within 8 months. Brain 
MRI, including suspectibility-weighted imaging, showed no abnormalities. Treatment with 
levodopa, trihexyphenidyl, clozapine, clonazepam, and botulinum toxin injections were of 
limited effect. We performed bilateral DBS of the internal globus pallidus (GPi). Pallidal 
stimulation with continuation of botulinum toxin injections in her neck muscles led to a 
substantial improvement at 12-month follow-up (Burke-Fahn-Marsden Dystonia Rating 
Scale [BFMDRS] 78 vs. 24.5; stimulation parameters: left/right GPi: 0-/8-; amplitude, 5.0V; 
pulse width: 90msec; frequency, 130 Hz). She regained her total independence, commu-
nication skills, and ability to walk (see Video 1)*.
Patient 2, the 49-year-old mother of the index patient, was born with sensory-neural hearing 
loss leading to deafness at the age of 6. She had no other developmental abnormalities 
(Fig. 1B,C). Aged 16, her hands started trembling, and 5 years later, she developed writer’s 
cramp. Her symptoms slowly progressed to dystonia of her trunk, neck, arms, and legs, and 
she became wheelchair dependent at 42. In addition, she suffered from a vital depression 
and auditory hallucinations. Because of increasing problems in daily functioning (BFMDRS, 
63.5) and stable psychiatric symptoms, she was recently treated with DBS and shows 
improvement of symptoms after 4 months (see Video 2*; stimulation parameters: left/




Figure 1. Face of proband (A) with remarkably high-arched eyebrows and her mother (B) with no facial abnormal-
ities. Pedigree of the family (C) showing proband (P) and mother as the only affected individuals.
Given that the positive family history pointed toward a genetic cause of DDS, mutations 
in the DYT1 gene, DDP1 gene (Mohr-Tranebjærg syndrome), and mitochondrial DNA were 
screened and excluded.[2] Single-nucleotide polymorphism array and targeted resequenc-
ing of 88 dystonia-associated genes associated did not lead to a causative gene.[2]
Whole-exome sequencing (WES) was performed after using the Agilent SureSelectXT 
Human All Exon 50 Mb Kit for exome capture (Agilent Technologies, Santa Clara, CA) by 
an Illumina HiSeq2000TM machine at BGI-Europa in Denmark. After “read alignment” with 
BWA and “variant calling” with GATK, variants were annotated by a program developed at 
the genetics department of the Radboud MC (Nijmegen, The Netherlands).[3] The gene 
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variants that were present in the genes of the hearing impairment gene panel, DGD141114, 
were selected and ranked according to their predicted pathogenicity. Reported variants 
were confirmed by Sanger sequencing of the variant. WES revealed a mutation in the 
beta-actin gene (ACTB) c.547C>T (p.Arg183Trp) in both mother and daughter.
DISCUSSION
Known genetic causes of DDS include Mohr-Tranebjærg syndrome, organic acidurias, 
Woodhouse-Sakati syndrome, and rare mitochondrial disorders. Here, we report on two 
cases from one family with a p.Arg183Trp mutation in ACTB encoding for cytoplasmatic 
actin (OMIM *102630).
ACTB mutations have been described with Baraitser-Winter syndrome. This is a develop-
mental disorder recognized by congenital ptosis, hypertelorism, high-arched eyebrows, 
and ocular colobomata and frequently associated with sensory-hearing deafness.[4] 
Verloes and colleagues advocated for a broader Baraitser-Winter cerebro-fronto-facial 
syndrome (BWCFF),[5] a heterogeneous disorder with muscular, visceral, and craniofacial 
involvement. Although definite diagnostic criteria are not established, facial anomalies with 
high-arched eyebrows appear to be the most consistent feature.
DDS has once been associated with the ACTB mutation in two identical twin brothers 
with the exact same as our patients. The boys presented with DDS and developmental 
abnormalities (cleft palate, hypertelorism, and achalasia) and normal brain imaging.[6] 
Dystonic symptoms started at the age of 12, generalized rapidly, and both died of aspiration 
pneumonias in their twenties. Post-mortem investigations suggested a neurodegenerative 
process with some iron accumulation in pallidal and nigral areas and aggregation of actin 
depolymerizing factor in eosinophilic rod-like structures in striatum and neocortex.[6]
Our index patient did have DDS but only showed minimal criteria (e.g. high-arched eyebrows) 
of BWCFF. Her mother suffered from isolated DDS. Taken together with the previously 
published twin brothers, the manifestation of DDS in all 4 patients carrying the p.Arg183Trp 
mutation makes the mutation highly suggestive of being causative. Interestingly, this is 
the first report of an autosomal-dominant inheritance, given that other ACTB mutations 
were reported as de novo.[5] Procaccio and colleagues previously suggested an autoso-




DBS is the treatment of choice in medical refractory dystonia.[7] Our index patient showed 
an excellent response to pallidal stimulation, regaining her independency and communica-
tion abilities. This is in line with two previous case reports of DDS, one genetic confirmed 
and one unconfirmed Mohr-Tranebjærg syndrome patient, both leading to more than 70% 
reduction of dystonic symptoms.[8,9]
In summary, the p.Arg183Trp mutation in the ACTB gene appears to be associated with an 
autosomal-dominant syndrome of DDS, with minimal or no classic characteristics of the 
BWCFF syndrome. We hypothesize that DDS and BWCFF are part of the same phenotypic 
spectrum of ACTB-gene mutations. Pallidal stimulation is to be considered to ameliorate 
invalidating dystonia in these patients.
* Videos can be found at https://onlinelibrary.wiley.com/doi/pdf/10.1002/mds.26842
LEGENDS TO THE VIDEOS
Video 1. The video shows the index patient sitting, pronating her arms, walking, and writing 
before (left) and 12 months after (right) bilateral DBS of the GPi. Before the operation, the 
patient was not able to sit in a chair, communicate by sign language, or walk because of 
her mobile dystonia. She was fed by a nasogastric tube, because of her dysphagia and 
subsequent weight loss. Twelve months after the surgery, her mobile dystonia was greatly 
reduced, leading to her ability to sit, walk, and communicate again. She was still in need of 
botulinum toxin injections in her neck to reduce the tonic neck dystonia.
Video 2. This video shows patient 2, mother of patient 1, in a sitting position, pronating her 
arms, finger tapping, and walking before (left) and 4 months after (right) bilateral pallidal 
stimulation. On this relatively short term, the stimulation led to reduction in her torticollis 
and a better ability to walk.
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